Differential Effects of Aripiprazole on D ₂ , 5-HT ₂ , and 5-HT _1A Receptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study

10.1124/jpet.102.033175

10.1016/j.ejphar.2005.02.051

Inoue T, 1996, J Pharmacol Exp Ther, 277, 137

10.1016/S0893-133X(98)00099-2

10.1016/S0893-133X(97)00112-7

10.1038/sj.npp.1300983

10.1016/S0014-2999(02)01532-7

Meltzer HY, 1989, Psychopharmacol Bull, 25, 390

10.4088/JCP.v63n0903

10.1016/S0893-133X(02)00304-4

Sheehan DV, 1998, J Clin Psychiatry, 59, 22

10.1093/schbul/13.2.261

Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare,1976, pp218-222

10.1111/j.1600-0447.1970.tb02066.x

10.1192/bjp.154.5.672

Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare,1976, pp534-537

10.1002/1098-2396(20001215)38:4<421::AID-SYN7>3.0.CO;2-X

10.1038/sj.npp.1380111

10.1111/j.1471-4159.1990.tb01229.x

10.1016/j.pscychresns.2006.01.011

10.1001/archpsyc.1987.01800190091013

10.1177/026988110401800304

10.1016/S0920-9964(98)00014-0

10.1002/ana.410150302

Ichise M, 2001, J Nucl Med, 42, 755

10.1097/00004647-200007000-00011

10.1006/nimg.1996.0066

10.1007/s00259-002-1025-9

10.1016/S0014-2999(97)01445-3

Millan MJ, 2000, J Pharmacol Exp Ther, 295, 853

Meller E, 1990, Mol Pharmacol, 37, 231

Nash JF, 1989, J Pharmacol Exp Ther, 249, 236

10.1177/026988110201600301

10.1111/j.1749-6632.1998.tb10179.x

10.1016/S0165-6147(00)88989-0

10.1017/S1461145704005000

10.1016/j.neuropharm.2005.02.005

10.1124/jpet.105.087163